Cancer prevention by targeting angiogenesis (Q38031118)

27 August 2017

Cancer prevention by targeting angiogenesis (English)

1 reference

27 August 2017

1 reference

1

1 reference

27 August 2017

4

1 reference

27 August 2017

Francesca Tosetti

2

1 reference

27 August 2017

Vincent W Li

series ordinal

3

1 reference

27 August 2017

William W Li

series ordinal

5

1 reference

27 August 2017

language of work or name

English

0 references

publication date

31 July 2012

1 reference

Nature Reviews Clinical Oncology

27 August 2017

1 reference

27 August 2017

9

1 reference

27 August 2017

9

1 reference

27 August 2017

498-509

1 reference

Projections of the cost of cancer care in the United States: 2010-2020.

27 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

The tumour microenvironment as a target for chemoprevention.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Screening for colorectal cancer: a guidance statement from the American College of Physicians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Prospective evaluation of whole-body cancer screening with multiple modalities including [18F]fluorodeoxyglucose positron emission tomography in a healthy population: a preliminary report.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Cancer prevention: from 1727 to milestones of the past 100 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Lifestyle: Breaking the cancer habit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Hallmarks of Cancer: The Next Generation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Transplacental carcinogenesis by stilbestrol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Antiangiogenic therapy--evolving view based on clinical trial results.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

31 March 2020

Cancer without disease.

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Tumor inflammatory angiogenesis and its chemoprevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Paradoxical roles of the immune system during cancer development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Inflammation, inflammatory cells and angiogenesis: decisions and indecisions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Tumour-educated macrophages promote tumour progression and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Tumor-associated neutrophils: friend or foe?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Proteolytic networks in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Angiogenesis inhibited by drinking tea.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Tumor invasion: molecular shears blunted by green tea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Natural and synthetic agents targeting inflammation and angiogenesis for chemoprevention of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Antiangiogenic mechanisms of diet-derived polyphenols

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Diet-derived phytochemicals: from cancer chemoprevention to cardio-oncological prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Topically applied imiquimod inhibits vascular tumor growth in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Increased endostatin generation and decreased angiogenesis via MMP-9 by tamoxifen in hormone dependent ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Reference profile correlation reveals estrogen-like trancriptional activity of Curcumin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Molecular targets for cancer chemoprevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Resveratrol suppresses colitis and colon cancer associated with colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

STATs in cancer inflammation and immunity: a leading role for STAT3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Diet-derived polyphenols inhibit angiogenesis by modulating the interleukin-6/STAT3 pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Infantile hemangioma-mechanism(s) of drug action on a vascular tumor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Endothelial cell aging and apoptosis in prevention and disease: E-selectin expression and modulation as a model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

The inhibition of autophagy potentiates anti-angiogenic effects of sulforaphane by inducing apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Chemopreventive agents induce a senescence-like phenotype in rat mammary tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Cancer stem cells and the tumor microenvironment: soloists or choral singers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Antiangiogenic activity of 2-deoxy-D-glucose

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Regulation of angiogenesis by oxygen and metabolism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Targeting mTOR pathways in human malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Metformin inhibits inflammatory angiogenesis in a murine sponge model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Pigment epithelium-derived factor increases in type 2 diabetes after treatment with metformin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Reactive oxygen species and endothelial activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Multiple points of intervention in the prevention of cancer and other mutation-related diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Metabolic regulation and redox activity as mechanisms for angioprevention by dietary phytochemicals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Curcumin: a component of the golden spice, targets multiple angiogenic pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Caloric restriction reduces growth of mammary tumors and metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Dietary soy and tea combinations for prevention of breast and prostate cancers by targeting metabolic syndrome elements in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Is it time to test metformin in breast cancer clinical trials?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Preventive therapy for breast cancer: a consensus statement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

CDDO-methyl ester delays breast cancer development in BRCA1-mutated mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Perspective: The big C - for Chemoprevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Clinical implications of cancer self-seeding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Angiopoietin2 and tie2: tied to lymphangiogenesis and lung metastasis. New perspectives in antimetastatic antiangiogenic therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

The 'chemoinvasion' assay, 25 years and still going strong: the use of reconstituted basement membranes to study cell invasion and angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Metronomic chemotherapy: new rationale for new directions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Phase II study of bevacizumab and chemoradiation in the preoperative or adjuvant treatment of patients with stage II/III rectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Designing smarter cancer prevention trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Surface-activated chemical ionization-electrospray ionization source improves biomarker discovery with mass spectrometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Platelet-associated PF-4 as a biomarker of early tumor growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Normal ranges of angiogenesis regulatory proteins in human platelets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Measurement of phosphorylated extracellular signal-regulated kinase 1 and 2 in an undergraduate teaching laboratory with ALPHAscreen technology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Epigenetic changes induced by curcumin and other natural compounds.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Polyphenolics from açaí ( Euterpe oleracea Mart.) and red muscadine grape (Vitis rotundifolia ) protect human umbilical vascular Endothelial cells (HUVEC) from glucose- and lipopolysaccharide (LPS)-induced inflammation and target microRNA-126.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Metastamirs: a stepping stone towards improved cancer management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Angioprevention with fenretinide: targeting angiogenesis in prevention and therapeutic strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Standards of medical care in diabetes--2009.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Antidiabetic therapies affect risk of pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

The ancient drug salicylate directly activates AMP-activated protein kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

The safety and efficacy of celecoxib in children with familial adenomatous polyposis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

C-reactive protein and risk of colorectal adenoma according to celecoxib treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Phase II trial of curcumin in patients with advanced pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Body mass index is directly associated with biomarkers of angiogenesis and inflammation in children and adolescents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Exoplanetary research. A distant glimpse of alien life?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Preferred therapies for neovascular age-related macular degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Extended results of the Alzheimer's disease anti-inflammatory prevention trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Evidence of angiogenic vessels in Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Effects of antioxidant components of AREDS vitamins and zinc ions on endothelial cell activation: implications for macular degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Angiogenesis modulates adipogenesis and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Vascular targeting of adipose tissue as an anti-obesity approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Vascular endothelial growth factor haplotypes associated with childhood obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.120

Flavonoids targeting of IκB phosphorylation abrogates carcinogen-induced MMP-9 and COX-2 expression in human brain endothelial cells

31 March 2020

1 reference

12 December 2020

Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis.

1 reference

12 December 2020

Tumor angiogenesis as a target for dietary cancer prevention

1 reference

12 December 2020

Antiangiogenesis in the treatment of skin cancer.

1 reference

12 December 2020

MicroRNAs: opening a new vein in angiogenesis research.

1 reference

12 December 2020

Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models.

1 reference

12 December 2020

Tumor angiogenesis: therapeutic implications

1 reference

12 December 2020

Imiquimod as an antiangiogenic agent.

1 reference

12 December 2020

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions

1 reference

12 December 2020

Stat bite: Lifetime risk of being diagnosed with cancer

1 reference

12 December 2020

Economic burden of renal cell carcinoma: Part I--an updated review

1 reference

12 December 2020

The chemopreventive effects of tea on human oral precancerous mucosa lesions

1 reference

12 December 2020

Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis

1 reference

12 December 2020

Chemoprevention of cancer with retinoids

1 reference

12 December 2020

Phenethyl isothiocyanate inhibits migration and invasion of human gastric cancer AGS cells through suppressing MAPK and NF-kappaB signal pathways.

1 reference

12 December 2020

Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.

1 reference

12 December 2020

10.1038/NRCLINONC.2012.120

Identifiers

DOI

1 reference

27 August 2017

1 reference